BeiGene and SpringWorks Therapeutics Announce the Formation of MapKure to Develop BGB-3245, an Investigational, Selective Next-Generation RAF Kinase Inhibitor

NEXT STORY
Global Healthcare Distribution Market Forecasts to 2024 – Growth in the Biosimilars Market / Increasing Specialty Drug Dispensing & Uptake of Biopharmaceuticals
PREV STORY
Tetra Bio-Pharma’s Management Provides Corporate Update Ahead of Annual General Meeting
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

RedHill Biopharma Provides Full-Year 2018 Financial Results and Operational Highlights

author_avatar
NASDAQ Market News

Generex Biotechnology Announces Webcast and Invites All Shareholders to See and Listen to the Corporate Presentation from the 21st Annual H.C. Wainwright Global Healthcare Investment Conference

author_avatar
NASDAQ Market News

Intensive Care Unit Equipment Market to Exhibit a CAGR of 4.8% and Reach USD 9.03 Billion by 2027; Inflated Demand for Ventilators During Coronavirus Pandemic to Exhibit Positive Sales Projections, states Fortune Business Insights™

author_avatar
NASDAQ Market News